News

Two teams of scientists have devised pathways around a synthetic biology roadblock by developing a set of machine learning algorithms that can analyze reams of RNA-based “toehold” sequences and predict which ones will be most effective at sensing and responding to a desired target sequence.

Researchers are working on strategies for designing a universal flu vaccine that could work against any flu strain.

A team from Purdue University has created a new platform to test how breast cancer cells respond to the recurrent stretching that occurs in the lungs during breathing.

A new study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted using the compound thymoquinone.

Researchers have now identified the neurons that are most affected by epilepsy – some have never been linked to epilepsy before.

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing”.

Leukemia modulates the bone marrow niche to protect and promote the survival of tumor cells. Scientists now show that this protective environment also gives leukemia cells with insufficient expression of BRCA1 and BRCA2 genes the ability to resist a specific type of anticancer drug called PARP inhibitors.

Researchers have demonstrated how a mysterious molecular concept named "range selectivity" could be used to target diseased cells with high specificity.

A drug has shown promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study involved treating mice with the drug, the KSP inhibitor prevented tumor growth and prolonged survival.

Scientists from the University of Geneva (UNIGE) have developed a technique for quickly identifying from a large number of existing drugs the optimal synergistic combination and dose of products that can kill tumour cells without affecting healthy cells.